GI Oncology
Conference Coverage
HCV patients with early-stage hepatocellular carcinoma can achieve SVR
Among patients with hepatocellular carcinoma, rates of sustained viral response to direct-acting regimens for hepatitis C virus were 79% for...
Conference Coverage
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...
Conference Coverage
Emergent colon cancer resection does not negatively affect patient outcomes
CORONADO, CALIF. – With the exception of patients that present with perforation, emergent resection of colon cancers does not appear to adversely...
From the Journals
Clinician fatigue not associated with adenoma detection rates in community-based setting
Neither time of day, nor number of procedures performed impacted adenoma detection rates in a community-based setting, a study has shown.
From the Journals
Lower mortality with left-sided colon tumors
Left-sided primary colon tumors are associated with significantly lower mortality than right-sided tumors, according to a systematic review and...
From the Journals
Oral bacterium linked to poor esophageal cancer survival
Fusobacterium nucleatum
Conference Coverage
Biomarker identifies precancerous pancreatic cysts
LAS VEGAS - In fluid derived from pancreatic cysts, methylated DNA markers predict the presence of high-grade dysplasia or cancer, and could help...
Conference Coverage
Automated colonoscopy risk classification for veterans
LAS VEGAS
News
Transcriptomics link gastric cancer to RNA misediting
Changes in the sequence of RNA – also known as RNA editing – might contribute to the pathogenesis and prognosis of gastric cancer, investigators...
Conference Coverage
Gastroesophageal cancers continue to make their mark globally
Studies emerging from around the world find the same patterns and similar rates of progression in both esophageal cancer and gastric cancer: 2%...
News
Lentinan missed primary endpoint in gastric cancer trial
A shiitake mushroom extract called lentinan did not improve overall survival in advanced gastric cancer when added to the oral fluoropyrimidine S-...